touchRESPIRATORY were delighted to speak with Prof. David Au (University of Washington, Seattle, WA, USA) to discuss the findings from the INSIGHT COPD study, investigating a lifestyle intervention in overweight patients with COPD.
‘Intervention Study in Overweight Patients with COPD (INSIGHT COPD): A Pulmonary Trials Cooperative Randomized Clinical Trial.‘ was presented at ATS 2022, 13-18 May 2022.
Questions
- What is known about the association between chronic obstructive pulmonary disease (COPD) and body weight? (0:20)
- Could you give us an overview of the lifestyle intervention you are investigating? (1:07)
- What are the methodology and eligibility criteria of the clinical trial that will evaluate this intervention? (2:21)
- What are the outcome measures of the study? (3:28)
- How well were these achieved? (4:13)
Disclosures: David Au discloses receiving grant/ research support from the Department of Veterans Affairs, NIH and American Lung Association; and honoraria from Boehringer Ingelheim.
Support: Interview and filming supported by Touch Medical Media Ltd. Interview conducted by Victoria Jones.
Filmed in coverage of the ATS meeting 2022.
